Review article: Liver transplantation for hepatocellular carcinoma

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 17, Issue 2, 2003, Pages 138-144

  Steinmuller T ^a   Jonas, S ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; CANCER INFILTRATION; CANCER MORTALITY; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC IMAGING; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 0037897745     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Engstrom PF, et al. Primary neoplasms of the liver. In: Holland, JF, Bast, RC, Morton, DL, Frei, E, Kufe, DW. Weichselbaum, RR. eds. Cancer Medicine, 4th edn. Baltimore, MD: Williams & Wilkins, 1997: 1923-38.
2. Ortner MA, Liebetruth J. Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536-42.
3. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8.
4. Vogl TJ, Mack MG, Roggan A, et al. Internally cooled power laser for MR-guided interstitial laser-induced thermotherapy of liver lesions: initial clinical results. Radiology 1998; 209: 381-5.
5. Livraghi T. Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-61.
6. Bruix J, Llovet JM, Castells A, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998; 27: 1578-83.
7. Tang ZY, Yu YQ, Zhou XD, Yang BH, Ma ZC. Lin ZY. Subclinical hepatocellular carcinoma, an analysis of 391 patients. J Surg Oncol 1993; 3(Suppl.): 55-8.
8. Tang ZY, Yu YO, Zhou XD. Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s. Semin Surg Oncol 1993; 9: 293-7.
9. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325: 675-80.
10. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211: 277-87.
11. MacIntosh EL, Minuk GY. Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstet 1992; 174: 245-54.
12. Jonas S, Bechstein WO. Kling N, Guckelberger O, Neuhaus P. Therapie des primären hepatozellulären Karzinoms. Dtsch Med Wochenschr 1997; 122: 617-20.
13. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-7.
14. Babineau TJ, Lewis WD, Jenkins RL, Bleday R, Steele GD Jr, Forse RA. Role of staging laparoscopy in the treatment of hepatic malignancy. Am J Surg 1994; 167: 151-4.
15. Lo CM, Lai EC, Liu CL, Fan ST, Wong J. Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg 1998; 227: 527-32.
16. Yokoyama I. Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991; 68: 2095-100.
17. Panis Y, Ribeiro J, Chretien Y, Nordlinger B. Dormant liver metastases: an experimental study. Br J Surg 1992; 79: 221-3.
18. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 218: 145-51.
19. Pichlmayr R. Weimann A, Oldhafer KJ, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995; 19: 807-13.
20. Michel J, Suc B, Montpeyroux F, et al. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 1997; 26: 1274-80.
21. Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S. Liver transplantation for hepatocellular carcinoma. World J Surg 1995; 19: 53-8.
22. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
23. Llovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998; 27: 1572-7.
24. Yuki K, Hirohashi S, Sakamoto M, Kanai T. Shimosato Y. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990; 66: 2174-9.
25. Mise K, Tashiro S, Yogita S, et al. Assessment of the biological malignancy of hepatocellular carcinoma, relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998; 4: 1475-82.
26. Torimura T, Sata M, Ueno T, et al. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol 1998; 29: 986-91.
27. Jinno K, Tanimizu M, Hyodo I, et al. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma. J Gastroenterol 1998; 33: 376-82.
28. Yamaguchi R, Yano H. Iemura A. Ogasawara S. Haramaki M. Kojiro M. Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 1998; 28: 68-77.
29. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701.
30. Olthoff KM, Rosove MH, Shackleton CR, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg 1995; 221: 734-41.
31. Okuda K, Nakashima T, Kojiro M, Kondo Y, Wada K. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology 1989; 97: 140-6.
32. Bismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995; 19: 35-41.
33. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214: 221-8.
34. Iwatsuki S, Starzl TE. Personal experience with 411 hepatic resections. Ann Surg 1988; 208: 421-34.
35. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46: 372-9.
36. Soreide O, Czerniak A, Bradpiece H, Bloom S, Blumgart L. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg 1986; 151: 518-23.
37. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988; 19: 784-94.
38. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228: 479-90.
39. Ringe B, Wittekind C, Weimann A, Tusch G, Pichlmayr R. Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet 1992; 175: 299-305.
40. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26: 877-83.
41. Jonas S, Weinrich M, Al-Abadi H, Steinbrich R. Tullius SG, Neuhaus P. Tumorzelldissemination hepatobiliärer Tumore. Z Gastroenterol 1998; 36: 78.
42. Jonas S, Bechstein WO, Steinmüller T, et al. Vascular invasion and histopathological grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080-6.